Susceptibility networks reveal independent patterns of brain iron abnormalities in multiple sclerosis.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
01 11 2022
Historique:
received: 21 04 2022
revised: 06 07 2022
accepted: 21 07 2022
pubmed: 26 7 2022
medline: 24 8 2022
entrez: 25 7 2022
Statut: ppublish

Résumé

Brain iron homeostasis is necessary for healthy brain function. MRI and histological studies have shown altered brain iron levels in the brains of patients with multiple sclerosis (MS), particularly in the deep gray matter (DGM). Previous studies were able to only partially separate iron-modifying effects because of incomplete knowledge of iron-modifying processes and influencing factors. It is therefore unclear to what extent and at which stages of the disease different processes contribute to brain iron changes. We postulate that spatially covarying magnetic susceptibility networks determined with Independent Component Analysis (ICA) reflect, and allow for the study of, independent processes regulating iron levels. We applied ICA to quantitative susceptibility maps for 170 individuals aged 9-81 years without neurological disease ("Healthy Aging" (HA) cohort), and for a cohort of 120 patients with MS and 120 age- and sex-matched healthy controls (HC; together the "MS/HC" cohort). Two DGM-associated "susceptibility networks" identified in the HA cohort (the Dorsal Striatum and Globus Pallidus Interna Networks) were highly internally reproducible (i.e. "robust") across multiple ICA repetitions on cohort subsets. DGM areas overlapping both robust networks had higher susceptibility levels than DGM areas overlapping only a single robust network, suggesting that these networks were caused by independent processes of increasing iron concentration. Because MS is thought to accelerate brain aging, we hypothesized that associations between age and the two robust DGM-associated networks would be enhanced in patients with MS. However, only one of these networks was altered in patients with MS, and it had a null age association in patients with MS rather than a stronger association. Further analysis of the MS/HC cohort revealed three additional disease-related networks (the Pulvinar, Mesencephalon, and Caudate Networks) that were differentially altered between patients with MS and HCs and between MS subtypes. Exploratory regression analyses of the disease-related networks revealed differential associations with disease duration and T2 lesion volume. Finally, analysis of ROI-based disease effects in the MS/HC cohort revealed an effect of disease status only in the putamen ROI and exploratory regression analysis did not show associations between the caudate and pulvinar ROIs and disease duration or T2 lesion volume, showing the ICA-based approach was more sensitive to disease effects. These results suggest that the ICA network framework increases sensitivity for studying patterns of brain iron change, opening a new avenue for understanding brain iron physiology under normal and disease conditions.

Identifiants

pubmed: 35878723
pii: S1053-8119(22)00619-X
doi: 10.1016/j.neuroimage.2022.119503
pmc: PMC10097440
mid: NIHMS1885848
pii:
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

119503

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS114227
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001412
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interests Robert Zivadinov has received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Keystone Heart, Protembis, and Novartis for speaking and consultant fees and has received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, Keystone Heart, Protembis, and V-WAVE Medical. Bianca Weinstock-Guttman has participated in speakers bureaus for, served as a consultant for, and/or received research support from Biogen, EMD Serono, Novartis, Genentech, Celgene/Bristol Meyers Squibb, Sanofi & Genzyme, Janssen, Horizon, Bayer, and LabCorp. Dr. Weinstock-Guttman also serves on the editorial board for BMJ Neurology, Children, CNS Drugs, MS International, and Frontiers Epidemiology.

Références

Neuroimage Clin. 2017 Nov 08;17:530-540
pubmed: 29201641
Mult Scler. 2012 Mar;18(3):322-8
pubmed: 21878451
Neurology. 2001 Oct 9;57(7):1239-47
pubmed: 11591843
J Trace Elem Med Biol. 2014 Jan;28(1):13-7
pubmed: 24075790
Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
Curr Opin Neurobiol. 2003 Oct;13(5):620-9
pubmed: 14630228
Front Immunol. 2018 Feb 19;9:255
pubmed: 29515576
Mol Neurobiol. 2021 Jun;58(6):2886-2896
pubmed: 33547621
J Magn Reson Imaging. 2015 Apr;41(4):1065-70
pubmed: 24841344
Neuroimage. 2021 Nov 15;242:118477
pubmed: 34403742
Am J Psychiatry. 2007 Mar;164(3):450-7
pubmed: 17329470
J Nucl Med. 2011 Mar;52(3):401-4
pubmed: 21321261
Radiology. 2018 Nov;289(2):487-496
pubmed: 30015589
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17648-53
pubmed: 25422429
Front Neurosci. 2021 Feb 18;15:618435
pubmed: 33679303
Front Hum Neurosci. 2013 May 20;7:216
pubmed: 23730284
Appl Opt. 2007 Sep 10;46(26):6623-35
pubmed: 17846656
Neuroimage. 2018 Feb 15;167:438-452
pubmed: 29097315
Biomedicines. 2019 Mar 19;7(1):
pubmed: 30893874
Front Aging Neurosci. 2018 Mar 12;10:65
pubmed: 29593525
IEEE Trans Med Imaging. 2004 Feb;23(2):137-52
pubmed: 14964560
J Biol Chem. 1980 May 10;255(9):4137-43
pubmed: 7372670
Hum Brain Mapp. 2021 Apr 1;42(5):1463-1474
pubmed: 33378095
Front Aging Neurosci. 2021 Apr 14;13:611891
pubmed: 33935681
Neuroimage Clin. 2017 Apr 13;18:1007-1016
pubmed: 29868452
Nat Chem Biol. 2014 Jan;10(1):9-17
pubmed: 24346035
Neuroreport. 2000 Jan 17;11(1):15-21
pubmed: 10683822
Neuroimage. 2011 Apr 15;55(4):1645-56
pubmed: 21224002
Sci Data. 2018 Nov 27;5:180270
pubmed: 30480664
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13040-5
pubmed: 19620724
Neuroradiology. 2022 Jul;64(7):1331-1342
pubmed: 34981175
Neuroimage. 2009 May 15;46(1):39-46
pubmed: 19457380
Clin Neuroradiol. 2015 Oct;25 Suppl 2:225-30
pubmed: 26198880
Neurobiol Aging. 2014 Sep;35 Suppl 2:S51-8
pubmed: 24929968
Ann Neurol. 2020 Jul;88(1):93-105
pubmed: 32285956
Neuroimage. 2008 Mar 1;40(1):35-42
pubmed: 18180169
Front Neurol. 2019 Aug 14;10:789
pubmed: 31474922
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
PLoS One. 2011;6(11):e28062
pubmed: 22140507
Ann Neurol. 2013 Dec;74(6):848-61
pubmed: 23868451
Radiology. 2013 May;267(2):531-42
pubmed: 23297322
Neurobiol Aging. 2007 Mar;28(3):414-23
pubmed: 16563566
Neuroimage. 2013 Apr 15;70:113-21
pubmed: 23277110
Neuroimage. 2011 Feb 14;54(4):2789-807
pubmed: 21040794
Front Neurol. 2019 Apr 30;10:450
pubmed: 31114541
Z Med Phys. 2016 Mar;26(1):6-34
pubmed: 26702760
Arch Neurol. 2000 Jan;57(1):65-70
pubmed: 10634450
Brain. 2017 Jan;140(1):118-131
pubmed: 27836833
Neurol Neuroimmunol Neuroinflamm. 2018 Mar 06;5(3):e443
pubmed: 29520366
Biochim Biophys Acta. 2009 Jul;1790(7):606-14
pubmed: 18778755
Radiology. 2009 Jul;252(1):165-72
pubmed: 19561255
Neuroimage. 2021 Oct 15;240:118371
pubmed: 34242783
J Neurochem. 1958 Oct;3(1):41-51
pubmed: 13611557
Neuroimage. 2020 Nov 1;221:117200
pubmed: 32745682
Neuroimage. 2012 Sep;62(3):2083-100
pubmed: 22659482
Int J Mol Sci. 2016 Jan 14;17(1):
pubmed: 26784172
Eur J Neurol. 2014 Aug;21(8):1137-e61
pubmed: 24779967
Neurology. 2015 Jun 16;84(24):2396-402
pubmed: 25979698
Glia. 1996 Jun;17(2):83-93
pubmed: 8776576
J Magn Reson Imaging. 2017 Nov;46(5):1474-1484
pubmed: 28263417
Neuroimage. 2018 Oct 1;179:117-133
pubmed: 29890327
Neuroimage. 2012 Sep;62(3):1593-9
pubmed: 22634862
Neuroimage. 2014 Apr 15;90:449-68
pubmed: 24389422
Cephalalgia. 2009 Mar;29(3):351-9
pubmed: 19025553
Neurobiol Aging. 2016 Jul;43:149-55
pubmed: 27255824
Neurosci Biobehav Rev. 2015 Jul;54:29-37
pubmed: 25862940
Br J Haematol. 2003 Mar;120(5):860-6
pubmed: 12614223
Mol Psychiatry. 2020 Nov;25(11):2932-2941
pubmed: 30778133
Neuroimage. 2014 May 1;91:412-9
pubmed: 24412399
Ann Thorac Surg. 2016 May;101(5):1644-5
pubmed: 27106412
Neuroreport. 2003 Mar 3;14(3):335-9
pubmed: 12634479

Auteurs

Jack A Reeves (JA)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Niels Bergsland (N)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA; MR Research Laboratory, IRCCS, Don Gnocchi Foundation ONLUS, Milan, Italy.

Michael G Dwyer (MG)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Center for Biomedical Imaging, Clinical and Translational Science Institute, Clinical and Translational Research Center, State University of New York at Buffalo, 6045C, 875 Ellicott Street, Buffalo, NY 14203, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Gregory E Wilding (GE)

Department of Biostatistics, School of Public Health and Health Professions, State University of New York at Buffalo, Buffalo, NY, USA.

Dejan Jakimovski (D)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Fahad Salman (F)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Balint Sule (B)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Nicklas Meineke (N)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Bianca Weinstock-Guttman (B)

Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA; Jacobs Neurological Institute, Buffalo, NY, USA.

Robert Zivadinov (R)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Center for Biomedical Imaging, Clinical and Translational Science Institute, Clinical and Translational Research Center, State University of New York at Buffalo, 6045C, 875 Ellicott Street, Buffalo, NY 14203, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.

Ferdinand Schweser (F)

Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA; Center for Biomedical Imaging, Clinical and Translational Science Institute, Clinical and Translational Research Center, State University of New York at Buffalo, 6045C, 875 Ellicott Street, Buffalo, NY 14203, USA; Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA. Electronic address: schweser@buffalo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH